Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer, July 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 293 articles:
HTML format


 

Single Articles

  1. HORIUCHI Y, Noguchi H, Taniguchi AY, Kazami M, et al
    Xanthoangelol, a chalcone from Angelica keiskei, induces apoptosis in cervical cancer cell lines via the oxidative stress-mediated activation of caspase-8 and caspase-9.
    Biochem Biophys Res Commun. 2026;830:154209.
    PubMed    
    Abstract available

  2. HERMANN KC, Peralta Chiriboga AA, Fuji KT, O'Keefe AL, et al
    Perceptions, knowledge, and access to the HPV vaccine among parents and healthcare providers in South Quito, Ecuador in 2025: A qualitative study.
    Glob Public Health. 2026;21:2697096.
    PubMed    
    Abstract available

  3. LIN R, Niu J, Weng S, Lin C, et al
    Label-free cervical cancer detection in tissue samples using Raman spectroscopy combined with machine learning technology.
    Anal Methods. 2026 Jul 3. doi: 10.1039/d6ay00509.
    PubMed    
    Abstract available

  4. PAZ-SOLDAN VA, Nussbaum L, Hidalgo C, Del Cuadro Hidalgo DL, et al
    Delivering cervical cancer screening and management to women in remote communities of the Peruvian Amazon: a mixed methods analysis of a mobile point-of-care intervention.
    Lancet Reg Health Am. 2026;61:101535.
    PubMed    
    Abstract available

  5. LIU Y
    Application of hydrogels in 3D tumor microenvironment modeling and drug screening for cervical cancer: A review.
    Bioeng Transl Med. 2026;11:e70147.
    PubMed    
    Abstract available

  6. KATANYOO K, Thavorncharoensap M, Kittisiam T
    Factors Affecting Quality of Life of Thai Cervical Cancer Patients.
    J Obstet Gynaecol Res. 2026;52:e70392.
    PubMed    
    Abstract available

  7. SANGONIYI OO, Dairo MD
    Barriers to accessing cervical cancer prevention services among out-of-school young women in Ibadan.
    BMC Womens Health. 2026 Jul 2. doi: 10.1186/s12905-026-04651.
    PubMed    
    Abstract available

  8. ABDULGHANI N, Faqih S, Alqurashi A, Baljon K, et al
    Effectiveness of an educational intervention in enhancing parents' knowledge, perception, and acceptability of human papillomavirus vaccine.
    BMC Public Health. 2026;26:2032.
    PubMed    
    Abstract available

  9. YADAV C, Nanda S, Sehrawat N, Yadav R, et al
    Molecular and bioinformatic analysis of apoptotic tumor suppressor genes in cervical cancer.
    J Appl Genet. 2026 Jul 3. doi: 10.1007/s13353-026-01093.
    PubMed    
    Abstract available

  10. YOUNG AP, Reyes R, Mgbudem C, Chen D, et al
    Primary HPV Testing for Cervical Cancer Screening Among Family Medicine Educators.
    J Am Board Fam Med. 2026;39:162481.
    PubMed    
    Abstract available


  11. Vaccination is helping to eliminate cervical cancer in several countries, and continued surveillance is essential.
    BMJ. 2026;394:e100162.
    PubMed    


  12. CUELLO MA, Gomez-Valenzuela F, Wichmann I, Olawaiye AB, et al
    Global feasibility of cervical cancer elimination: a multidimensional scenario-based modelling analysis across 175 countries.
    Lancet Glob Health. 2026 Jul 2:104008. doi: 10.1016/j.langlo.2026.104008.
    PubMed    
    Abstract available

  13. RAMALIBA TM, Muchengeti MM, Sithole N, Motlhale M, et al
    Incidence patterns and temporal trends of breast, prostate, oesophageal and cervical cancer in rural Eastern Cape Province, South Africa 1998-2021.
    Cancer Epidemiol. 2026;103:103151.
    PubMed    
    Abstract available

  14. H CHUWA A
    Innovations in HPV vaccination and their role in global cervical cancer control: a review.
    Ther Adv Vaccines Immunother. 2026;14:25151355261449446.
    PubMed    
    Abstract available

  15. YUAN Y, He W, Tong L, Yang Y, et al
    Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report.
    Front Immunol. 2026;17:1853610.
    PubMed    
    Abstract available

  16. FENG S, Huang Y, Li Z, He Z, et al
    A mitochondrial regulatory network of ferroptosis defense in HPV-positive cervical cancer: therapeutic implications of the mitoSTAT3-DHODH axis.
    Front Pharmacol. 2026;17:1868059.
    PubMed    
    Abstract available

  17. XU M, Lu T, Lv Q, Mo K, et al
    Integrative network pharmacology, molecular dynamics simulation, and single-cell RNA sequencing strategies reveal the multi-target mechanisms of oridonin against cervical cancer.
    Front Pharmacol. 2026;17:1788376.
    PubMed    
    Abstract available

  18. FILE BH, Rara MR, Nemmani RS, Chang J, et al
    Sociodemographic disparities and hospice referral practice patterns among patients with recurrent cervical cancer.
    Gynecol Oncol Rep. 2026;66:102151.
    PubMed    


  19. JIA C, Wu Y, Gao F, Liu W, et al
    Corrigendum to "The opposite role of lactate dehydrogenase a (LDHA) in cervical cancer under energy stress conditions" [Free Radic. Biol. Med. 214 (2024) 2-18].
    Free Radic Biol Med. 2026 Jul 1:S0891-5849(26)00910.
    PubMed    


  20. DEWI SUGANDA PUTRI MP
    [Reading cervical cancer as an issue of gender justice and human rights].
    Aten Primaria. 2026;58:103563.
    PubMed    


  21. GEORGE J, Amoo-Mitchual S, Kernell C, Tuli S, et al
    Adherence to Survivorship Care Visits in Patients With Cervical Cancer in Botswana.
    JCO Glob Oncol. 2026;12:e2500352.
    PubMed    
    Abstract available

  22. KANBAS CO, Keles E, Mert EO, Ozdas CE, et al
    Prognostic impact of adenomyosis in cervical cancer: insights from machine learning-driven survival analysis.
    Rev Assoc Med Bras (1992). 2026;72:e20251656.
    PubMed    
    Abstract available

  23. ZHAO YH, Ruan QF, Ning JH, Zhang X, et al
    Bidirectional mendelian randomization identifies plasma proteins associated with cervical cancer risk.
    J Egypt Natl Canc Inst. 2026;38:40.
    PubMed    
    Abstract available

  24. RAN L, Lian Z, Tian Y, Qin L, et al
    Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation.
    Front Immunol. 2026;17:1850891.
    PubMed    
    Abstract available

  25. JAKIMIUK AJ, Januszewski M
    Towards HPV-Based Cervical Cancer Screening in Poland: Lessons From a Landmark Trial.
    Lancet Reg Health Eur. 2026;66:101752.
    PubMed    


  26. ROCKWELL MS, Fendrick AM
    Optimizing the Uptake and Completion of the Cervical Cancer Screening Continuum: Opportunity Knocks, Including at Home.
    Cancer Epidemiol Biomarkers Prev. 2026;35:1061-1063.
    PubMed    
    Abstract available

  27. THONGSAWAD S, Rinjan N, Tharavichitkul E, Khamfongkhruea C, et al
    Deep learning-based dose prediction to enhance planning efficiency in cervical brachytherapy with hybrid applicators.
    Phys Med Biol. 2026;71.
    PubMed    
    Abstract available

  28. MUDRIK A
    Large Language Models on European Guidelines for Cervical Cancer: Implications of Design and Clinical Applicability.
    BJOG. 2026 Jun 30. doi: 10.1111/1471-0528.70299.
    PubMed    


  29. AMAOUI B, Belkadi C, Dlhane M, Amrani M, et al
    Performance of the cervical cancer screening program in Souss-Massa, Morocco: evidence for strategic transition toward HPV testing.
    BMC Womens Health. 2026 Jul 1. doi: 10.1186/s12905-026-04644.
    PubMed    
    Abstract available

  30. SINGINI MG, Sitas F, Basu P, Kengne AP, et al
    Factors associated with cervical cancer screening in the South African demographic and health survey.
    Cancer Causes Control. 2026;37:113.
    PubMed    
    Abstract available

  31. SAITO M, Hasegawa T, Ohtani A, Gocho T, et al
    Risk Factors for Sacral Insufficiency Fracture After Pelvic Irradiation for Cervical Cancer.
    In Vivo. 2026;40:2436-2444.
    PubMed    
    Abstract available

  32. KAWAMURA Y, Yoshida K, Morita H, Nakai M, et al
    Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc Analysis.
    In Vivo. 2026;40:2389-2397.
    PubMed    
    Abstract available

  33. ZHANG S, Ye D, Xiu Y, Liu H, et al
    Habitat heterogeneity analysis of planning CT improves the prediction of radiation proctitis in cervical cancer: A multimodal machine learning study.
    Appl Radiat Isot. 2026;236:112763.
    PubMed    
    Abstract available

  34. SUNDSTROM K
    Welcome reduction of US cervical cancer rates despite state differences.
    J Natl Cancer Inst. 2026 Jun 30:djag107. doi: 10.1093.
    PubMed    


  35. PENG P, Yin Y, Zhang B, Yao S, et al
    Treatment Patterns and Decision Drivers in Chinese Patients with Locally Advanced Cervical Cancer: Results from a National Physician Survey.
    Adv Ther. 2026 Jun 30. doi: 10.1007/s12325-026-03619.
    PubMed    
    Abstract available

  36. RASPAGLIESI F, Bogani G, Lanteri P
    ASO Visual Abstract: Revisiting the Concept of Nerve-Sparing Radical Hysterectomy: A Proof-of-Concept Prospective Study from a Cervical Cancer Cohort.
    Ann Surg Oncol. 2026 Jun 30. doi: 10.1245/s10434-026-20090.
    PubMed    


  37. HIMAL I, S K, G S A
    miR-4687-3p modulates cell proliferation and migration in cervical cancer cells.
    Mol Biol Rep. 2026;53:1065.
    PubMed    
    Abstract available

  38. CAO D, Shi F, Huang Y, Zhang L, et al
    Machine learning-assisted SERS for rapid and accurate early screening of cervical cancer.
    Anal Bioanal Chem. 2026 Jun 30. doi: 10.1007/s00216-026-06619.
    PubMed    
    Abstract available

  39. DHOLLANDER N, Jaafar I, Almonte M, Rezhake R, et al
    Accuracy of colposcopy to triage HPV-positive women in cervical cancer screening: a systematic review and meta-analysis.
    EClinicalMedicine. 2026;96:104009.
    PubMed    
    Abstract available

  40. YANG J, Zhang Y, Wu Y, Wang Y, et al
    Symptom Clusters and Quality of Life in Cervical Cancer Patients During the Perioperative Period: A Longitudinal Study.
    Patient Prefer Adherence. 2026;20:589862.
    PubMed    
    Abstract available

  41. DONGRE TA, Karmarkar PJ, Gowardhan VP, Hajare S, et al
    A cross-sectional analytical study assessing apoptotic index as a marker of disease progression in cervical dysplasia.
    Pan Afr Med J. 2026;53:81.
    PubMed    
    Abstract available

  42. YANG Y, Zhu X, Hu D
    Case Report: Metastatic right ventricular tumor and pulmonary embolism from cervical cancer post COVID-19 infection.
    Front Immunol. 2026;17:1845280.
    PubMed    
    Abstract available

  43. KANG OJ, Kim Y, Nam SH, Lee SW, et al
    Gastric-type Histology Independently Predicts Poor Survival in Surgically-treated Cervical Adenocarcinoma.
    Anticancer Res. 2026;46:3927-3937.
    PubMed    
    Abstract available

  44. NAKAI M, Yoshida K, Morita H, Kawamura Y, et al
    Association Between Brachytherapy and Acute Diarrhea During Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study.
    Anticancer Res. 2026;46:3907-3917.
    PubMed    
    Abstract available

  45. NGUYEN DTN, Islam R, Qin J, Senkomago V, et al
    Cervical cancer burden and elimination readiness in the US-affiliated Pacific Islands: A structured narrative review.
    Cancer Epidemiol. 2026;103:103144.
    PubMed    
    Abstract available

  46. YILMAZ H, Erkal Aksoy Y
    Privacy concerns, fear of pain, and health anxiety in women participating in cervical cancer screening: A cross-sectional study.
    Health Care Women Int. 2026 Jun 29:1-23. doi: 10.1080/07399332.2026.2695619.
    PubMed    
    Abstract available

  47. YUAN M, Li J, Huang Y, Liang Y, et al
    miR-524-5p suppresses cervical cancer progression through targeting the LRP6/Wnt/beta-catenin axis.
    J Mol Histol. 2026;57:213.
    PubMed    
    Abstract available

  48. ARROYO MUHR LS, Yilmaz E, Lagheden C, Eklund C, et al
    Global Performance of Human Papillomavirus Typing, Screening, and Evaluation As Assessed Using Proficiency Panels Traceable to International Standards: A Retrospective Analysis, 2008-2024.
    J Med Virol. 2026;98:e71033.
    PubMed    
    Abstract available

  49. PARVATHY N, Gupta N
    Cervical Cancer Screening in the Molecular Era: Integrating Cytology, Human Papillomavirus Testing, and Biomarkers.
    J Cytol. 2026;43:59-62.
    PubMed    
    Abstract available

  50. WANG Y, Luo C, Li Y, Pei J, et al
    Inflammatory biomarker-based prognostic model for immunotherapy outcomes in patients with recurrent or metastatic cervical cancer.
    Front Oncol. 2026;16:1818240.
    PubMed    
    Abstract available

  51. CARDOSO L, Saidu R, Kuhn L
    Screen-and-treat: a sustainable solution for cervical cancer elimination in low and middle income countries.
    BMJ Oncol. 2026;5:e000827.
    PubMed    
    Abstract available

  52. PRIYA S, Panigrahi SK, Bansal V, Arnav A, et al
    Artificial Intelligence Colposcopy Models for Cervical Cancer Screening and Diagnosis: A Systematic Review and Meta-Analysis.
    J Obstet Gynaecol India. 2026;76:192-199.
    PubMed    
    Abstract available

  53. ARRIVILLAGA M, Neira D, Rivero DS, Vargas-Cardona HD, et al
    CITOBOT AI for real-world cervical cancer screening using colposcopy imaging.
    Front Public Health. 2026;14:1802494.
    PubMed    
    Abstract available

  54. NAKAMURA H, Mori S, Ishii Y, Takeuchi T, et al
    Prevalence and genotype distribution of human papillomavirus in cervical cancer and precancer in Japan between 2012 and 2025: a retrospective single-center study.
    Front Public Health. 2026;14:1857364.
    PubMed    
    Abstract available

  55. HARUN SNF, Azlan AA, Mohd Hassan NZA, Mohamad EMW, et al
    Health belief model and cervical cancer screening intention among lower socioeconomic women in Malaysia: a pilot study.
    Front Public Health. 2026;14:1843558.
    PubMed    
    Abstract available

  56. BEGUM T, Jacob L, L K R, M C SB, et al
    A Comparative Analysis of Carboplatin- and Cisplatin-Based Concurrent Chemoradiation for Treating Locally Advanced Cervical Cancer: A Single-Center Observational Study.
    Cureus. 2026;18:e109724.
    PubMed    
    Abstract available

  57. GU X, Zhang Y, Xu Z, Guan R, et al
    [An auxiliary diagnosis system for cervical intraepithelial neoplasia based on colposcopic images].
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2026;43:496-503.
    PubMed    
    Abstract available

  58. KASSICK M, Pain D, Becht K, Adefres B, et al
    Barriers to the use of brachytherapy for treatment of cervical cancer and prostate cancer in low- and middle-income countries.
    Expert Rev Anticancer Ther. 2026 Jun 28:1-12. doi: 10.1080/14737140.2026.2684631
    PubMed    
    Abstract available

  59. YU JS, Park G, Seo H, Kim YH, et al
    Biology-aligned cervical cancer screening: target-centric biomarkers and next-generation diagnostic platforms.
    Biomark Res. 2026 Jun 27. doi: 10.1186/s40364-026-00964.
    PubMed    
    Abstract available

  60. KABEKKODU SP, Rodrigues AF, Hebbar P, Bhat S, et al
    Identification and validation of stemness-associated hub genes in cervical cancer: a bioinformatics and experimental study.
    World J Surg Oncol. 2026 Jun 27. doi: 10.1186/s12957-026-04472.
    PubMed    
    Abstract available

  61. OKOVA D, Lukwa AT, Cunnama L
    Geospatial Analysis of HIV Prevalence and Cervical Cancer Screening Coverage in Sub-Saharan Africa: Opportunities and Gaps for Integrated Care.
    Value Health Reg Issues. 2026 Jun 26:101670. doi: 10.1016/j.vhri.2026.101670.
    PubMed    
    Abstract available

  62. BABA SK, Jawwad T, Al Menhali A, Mirza S, et al
    An innovative course-based undergraduate research experience (CURE) in HPV-associated cervical cancer: integrating molecular oncology research and scientific writing in undergraduate education.
    J Microbiol Biol Educ. 2026 Jun 22:e0008526. doi: 10.1128/jmbe.00085.
    PubMed    
    Abstract available

  63. WU M, Guo Y, Yang J, Wang E, et al
    LKB1 attenuates the transport activity of GLUT1 by regulating the alternative splicing of PKM1/PKM2 in cervical cancer.
    J Gynecol Oncol. 2026 Jun 16. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  64. SAHA A, Churchill V, Rodriguez AD, Kursuncu U, et al
    Large Language Models for Breast and Cervical Cancers Communication: Mixed Methods Evaluation Study Assessing Linguistic Quality, Safety, and Accessibility.
    JMIR Cancer. 2026;12:e82971.
    PubMed    
    Abstract available

  65. LENCHA B, Geda B, Ahmed K, Kapps L, et al
    Follow-up rescreening among women living with human immunodeficiency virus who tested positive and treated for cervical pre-cancer lesions in South Ethiopia.
    Oncologist. 2026;31:oyag237.
    PubMed    
    Abstract available

  66. ALMEIDA EA, Arora M, Mehndiratta M, Agarwal R, et al
    CRISPR/Cas in gynecologic cancers: A review of experimental and therapeutic applications.
    Indian J Cancer. 2026;63:1-8.
    PubMed    
    Abstract available

  67. SILVA LVC, Silva KL, Rezende LC, Moreira ALA, et al
    Nursing interventions for health education of incarcerated women: a systematic review.
    Patient Educ Couns. 2026;150:109733.
    PubMed    
    Abstract available

  68. ABULAIZI M, Aili M, Du Z, Xiong J, et al
    Bi-A@SR Nanoparticles Enable Tumor-Localized NO Release to Suppress HSP70 and Reverse Chemoresistance.
    Adv Healthc Mater. 2026;15:e71321.
    PubMed    
    Abstract available

  69. GODOY-VITORINO F, Vargas-Robles D, Bolanos-Rosero B, Pagan-Zayas N, et al
    Environmental fungi modulate the vaginal mycobiome and cervical disease progression in Hispanic women.
    mSystems. 2026;11:e0005626.
    PubMed    
    Abstract available

  70. YUAN L, Wang H, Xu Z, Liu K, et al
    Analysis of factors influencing the missed diagnosis of cervical precancerous lesions by colposcopy.
    BMC Womens Health. 2026;26:333.
    PubMed    
    Abstract available

  71. ZHANG T, Zhang H, Wei Y, Wang D, et al
    A repeated cross-sectional analysis of routine leucorrhea test results in women from Jianyang City, Western China (2022-2024) and exploration of the significance of health screening.
    BMC Womens Health. 2026;26:322.
    PubMed    
    Abstract available

  72. SETH A, Gupta RK, Nanda S, Sonkar PK, et al
    Evaluation of immunohistochemical expression of sex-determining region Y-box 2 and Antigen Kiel 67 in squamous cell carcinoma cervix and its correlation with histological and clinical parameters.
    Indian J Pathol Microbiol. 2026;69:233-239.
    PubMed    
    Abstract available

  73. KESSESSA HM, Mogus AT, Woldeamanuel Y
    Human papillomavirus vaccine uptake and associated factors among schoolgirls in Sululta and Chancho towns, Central Ethiopia: a cross-sectional study.
    BMC Infect Dis. 2026;26:1133.
    PubMed    
    Abstract available

  74. KILAVUZ M, Genc R, Topaloglu S, Avcu E, et al
    HPV vaccine: the key to a powerful shield against cancer.
    BMC Public Health. 2026;26:1850.
    PubMed    
    Abstract available

  75. HUANG XX, Yao P, Wang Q, Sun PM, et al
    Policy window period: analysis of HPV vaccination status among age-eligible girls in China (before national immunisation programme implementation).
    BMC Womens Health. 2026;26:288.
    PubMed    
    Abstract available

  76. CANCHOLA AJ, Pruitt SL, Lin K, Boscoe FP, et al
    Ethnic Enclave Residence and Breast, Cervical, and Colorectal Cancer Incidence among Asian American Adults, 2006 to 2017.
    Cancer Epidemiol Biomarkers Prev. 2026;35:1139-1150.
    PubMed    
    Abstract available

  77. CHEN M, Wang X, Abudurehemu S, Li L, et al
    Thermal ablation plus HPV-specific IgY vaginal gel versus watchful waiting in women with histologically confirmed CIN1 and persistent HPV: a prospective observational cohort study.
    BMC Womens Health. 2026;26:299.
    PubMed    
    Abstract available

  78. GOKKAYA M, Yalcin N, Alci A, Taskum I, et al
    Evaluation of ChatGPT-5-generated clinical management recommendations for HPV infection and cervical premalignant lesions: a scenario-based expert assessment study.
    BMC Med Inform Decis Mak. 2026;26:197.
    PubMed    
    Abstract available

  79. MULCAHY SYMMONS S, Drury A, Darley A, Kroll T, et al
    Co-designing solutions to promote awareness of cervical screening with women of low socio-economic position living in urban areas.
    BMC Public Health. 2026;26:1742.
    PubMed    
    Abstract available

  80. MOHAMED HRH, Elhaggan SO, Hekal RS, Fahmy CWH, et al
    Yttrium oxide nanoparticles induce potent selective cytotoxicity in HeLa cervical cance cells through ROS-mediated genomic instability and mitochondrial apoptosis.
    Sci Rep. 2026;16:12239.
    PubMed    
    Abstract available

  81. BADRALDIN SQ, Alfarttoosi KH, Sameer HN, Bishoyi AK, et al
    The Clinical Significance of KIFs in Cervical and Endometrial Cancer: from Mechanisms to Biomarker and Therapeutic Potential.
    Reprod Sci. 2026;33:1091-1109.
    PubMed    
    Abstract available

  82. LIU H, He Y, Geng W, Huang Y, et al
    The effect of estrogen and its receptors on the progression of cervical intraepithelial neoplasia in postmenopausal women through synergistic interaction with HPV.
    BMC Womens Health. 2026;26:254.
    PubMed    
    Abstract available

  83. WANG S, Song Q, Ma C, Dong D, et al
    Predicting the biological behavior of cervical squamous cell carcinoma: a machine learning approach using apparent transverse relaxation rate (R2* maps) radiomics nomogram.
    BMC Med Imaging. 2026;26:303.
    PubMed    
    Abstract available

  84. MALING S, Ssedyabane F, Mudondo H, Kajabwangu R, et al
    Depression and loss to follow-up among patients treated for premalignant cervical lesions at a tertiary hospital in Uganda: a cross-sectional study.
    BMC Womens Health. 2026;26:243.
    PubMed    
    Abstract available

  85. CHERIF A, Engelbrecht K, Ovcinnikova-Hutchings O, Ntais D, et al
    Age of acquisition of disease-causal human papillomavirus infection to high-grade cervical intraepithelial neoplasia (CIN2+) in England.
    BMC Infect Dis. 2026;26:680.
    PubMed    
    Abstract available

  86. HABIBA U, Islam N
    Synergistic anticancer effects of thymoquinone and curcumin via ROS-mediated mitochondrial apoptosis in HeLa cells.
    Mol Biol Rep. 2026;53:557.
    PubMed    
    Abstract available

  87. YU M, Jiang M, Zhang X, Chen H, et al
    Adenocarcinoma admixed with neuroendocrine carcinoma of the cervix: a clinicopathological diagnostic study and molecular features.
    Diagn Pathol. 2026;21:46.
    PubMed    
    Abstract available

  88. UMUTESI G, Weiner BJ, Jewell T, Kapiga S, et al
    A framework policy analysis of single-dose HPV vaccination adoption in East Africa: a rapid review.
    BMC Health Serv Res. 2026;26:608.
    PubMed    
    Abstract available

  89. WANG M, Xu J, Xu S, Wu Y, et al
    HPV status as a predictor of ovarian metastasis in cervical adenocarcinoma: implications for surgical decision-making.
    BMC Womens Health. 2026;26:227.
    PubMed    
    Abstract available

  90. GHORBEL A, Zelaiti H, Saidi S, Liouane F, et al
    Evaluation of HPV awareness among parents of adolescent girls in Tunisia: a cross-sectional study.
    Sci Rep. 2026;16:13704.
    PubMed    
    Abstract available

  91. YAN L, Wang Z, Shen X, Yang J, et al
    Time-lapsed colposcopy image-based segmentation of cervical lesion areas.
    Sci Rep. 2026;16:13344.
    PubMed    
    Abstract available

  92. YORKE AA, Ignatius K, Schreiner JL, Kron T, et al
    Estimating the Carbon Footprint of External Beam Radiotherapy: Should This Be a Concern for LMICs?
    J Med Imaging Radiat Oncol. 2026;70:395-400.
    PubMed    
    Abstract available

  93. AXELROD ML, Zhou R, Sun L
    Spatial transcriptomic landscape of invasion patterns in human papillomavirus-associated endocervical adenocarcinoma.
    Sci Rep. 2026;16:13246.
    PubMed    
    Abstract available

  94. DAI W, Jiang X, Liu Y, Yu Y, et al
    Integrated cross-sectional study and functional validation indicate the association of lactobacillus crispatus-derived D-lactic acid with cervical gene expression and precancerous cervical lesions.
    J Transl Med. 2026;24:511.
    PubMed    
    Abstract available

  95. JIANG Z, Hua Y, Xu S, Li M, et al
    Bilibili/TikTok videos as sources of HPV-related medical information: a cross-sectional content analysis.
    BMC Public Health. 2026;26:1225.
    PubMed    
    Abstract available

  96. BARTHOLOMEW K, Maxwell A, Yang LPH, Aye PS, et al
    Clinician and patient experiences with opportunistic offer of HPV self-testing in Aotearoa New Zealand primary care clinics: interview and survey findings.
    BMC Prim Care. 2026;27:147.
    PubMed    
    Abstract available

  97. TAO H, Tong Z, Li H, Mao S, et al
    Development and interpretability of an XGBoost model to predict high grade cervical intraepithelial neoplasia.
    BMC Med Inform Decis Mak. 2026;26:100.
    PubMed    
    Abstract available

  98. GAO X, Liu Z, Xu Z, Liu K, et al
    Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient.
    Cell Oncol (Dordr). 2026;49:48.
    PubMed    
    Abstract available

  99. SADEGHI Z, Jazayeri SM, Pirkooh AA, Foroushani AR, et al
    Cell cycle gene expression and microbial profiles associated with HPV related cervical neoplasia and cervical microbiome shifts.
    Sci Rep. 2026;16:10310.
    PubMed    
    Abstract available

  100. ZHAO C, Cai Y
    Cervical HSIL and Microinvasive Squamous Cell Carcinoma With Superficial Spread to Endometrium and/or Fallopian Tube Epithelium: Clinical and Pathological Findings in 2 Patients and Literature Review.
    Int J Surg Pathol. 2026;34:1256-1264.
    PubMed    
    Abstract available

  101. MITCHELL L, Wong D, Butler T, Brotherton J, et al
    Implementing HPV self-collection: a scoping review of facilitators and strategies among Indigenous women and people with a cervix.
    BMC Public Health. 2026;26:1053.
    PubMed    
    Abstract available

  102. ONYENOBI E, Zhong M, Peitz J, Chawla K, et al
    Identification of miRNA biomarkers and development of predictive signatures for early detection and prognosis in cervical precancer and cancer.
    Hum Genomics. 2026;20:60.
    PubMed    
    Abstract available

  103. MUMUKUNDE M, Dusengumuremyi T, Polo A, Hande V, et al
    A mixed-methods evaluation of a patient navigation program for breast and cervical cancers in Rwanda.
    BMC Public Health. 2026;26:1027.
    PubMed    
    Abstract available

  104. KINION JH, McAllister MB, Summerton JE, Dolan BP, et al
    LK-1: an investigational therapy targeting hCG-beta in metastatic breast, bladder, ovarian, and cervical cancers.
    Sci Rep. 2026;16:10061.
    PubMed    
    Abstract available

  105. CHIPANTA D, Osborne C, Bohlius J, Shakarishvili A, et al
    Impact of the 2013 WHO guidelines for screening and treatment of cervical pre-cancerous lesions on women's screening uptake, by HIV-status, in Eastern and Southern Africa: a regression discontinuity design analysis.
    Reprod Health. 2026;23:86.
    PubMed    
    Abstract available

  106. NURMAINI S, Rachmatullah MN, Agustiansyah P, Sanif R, et al
    AI-assisted diagnosis of cervical dysplasia from cervicography images.
    Sci Rep. 2026;16:9920.
    PubMed    
    Abstract available

  107. RAKAB MS, Baklola M, Hafez H, Abbas SHZ, et al
    Cultural and religious influences on parental knowledge of HPV infection and female vaccination in Egypt: a national cross-sectional study.
    BMC Public Health. 2026;26:1109.
    PubMed    
    Abstract available

  108. MA J, Deng P, Lin B, Luo P, et al
    Mapping the global research landscape on HPV vaccine hesitancy: a machine-learning based bibliometric analysis.
    Virol J. 2026;23:81.
    PubMed    
    Abstract available

  109. DANESHI N, Mahmoudi M, Rezaee SA, Khoshmirsafa M, et al
    Effects of nanosilymarin and conditioned medium of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells co-cultured with HeLa cells.
    BMC Complement Med Ther. 2026;26:107.
    PubMed    
    Abstract available

  110. HU Y, Li D, Qiu L, Di W, et al
    Occult cervical large cell neuroendocrine carcinoma masquerading as adenocarcinoma in situ during pregnancy: a case report, literature review, and SEER analysis.
    BMC Pregnancy Childbirth. 2026;26:421.
    PubMed    
    Abstract available

  111. BRENNER EJ, Allison BA, Berenblum Tobi C, Kamoun C, et al
    Reproductive Health in Young and Adolescent Females with Inflammatory Bowel Disease.
    Curr Gastroenterol Rep. 2026;28:8.
    PubMed    
    Abstract available

  112. TASEEN S, Ayub R, Noman GEL, Yousafzai MT, et al
    Leveling up immunization: a systematic review of gamification interventions to improve Human Papillomavirus (HPV) vaccine uptake.
    BMC Public Health. 2026;26:911.
    PubMed    
    Abstract available

  113. FAGHIR-GANJI M, Feizabadi P, Ansari-Moghaddam A, Abdolmohammadi N, et al
    HPV vaccination in Iran: expert perspectives on family dynamics and barriers.
    BMC Womens Health. 2026;26:135.
    PubMed    
    Abstract available

  114. SAHIN M, Buran A, Arslanca T, Ucar YO, et al
    Role of COVID-19 in the persistence of cervical high-risk human papillomavirus: a non-randomized retrospective study.
    BMC Womens Health. 2026;26:117.
    PubMed    
    Abstract available

  115. WU W, Ren X, Chen Y, Du W, et al
    4-Nonylphenol regulates cell proliferation and apoptosis in cervical carcinoma through the MEG3/PI3K/AKT signaling pathway.
    Sci Rep. 2026;16:6067.
    PubMed    
    Abstract available

  116. LUO L, Wang L, Liu Z, Cai Y, et al
    PAX1/JAM3 methylation in cervical exfoliated cells: a robust diagnostic biomarker for cervical high-grade lesions associated with vaginal dysbiosis.
    BMC Womens Health. 2026;26:108.
    PubMed    
    Abstract available

  117. KAYA MB, Uzun E
    Utility of SOX2 in the diagnosis of squamous intraepithelial lesions and squamous cell carcinoma of cervix uteri.
    BMC Womens Health. 2026;26:101.
    PubMed    
    Abstract available

  118. OZEN S, Ozen EG, Simsek GO, Arzik AO, et al
    HPV persistence and CIN2 + Detection in women with normal cytology and Non-16/18 High-Risk HPV positivity.
    BMC Womens Health. 2026;26:98.
    PubMed    
    Abstract available

  119. HOJEN IB, Kristensen MK, Bertelsen VM, Tranberg M, et al
    Effect of coriolus versicolor-based vaginal gel on clearance of human papillomavirus and cervical dysplasia - a scoping review.
    BMC Womens Health. 2026;26:71.
    PubMed    
    Abstract available

  120. THOMPSON JH, Rivelli JS, Gautom P, Petrik AF, et al
    Co-creating HPV Vaccination Messages for Rural Washington: Application of a Boot Camp Translation Approach.
    Health Educ Behav. 2026;53:367-376.
    PubMed    
    Abstract available

  121. YUE C, Liu S, Wang W, Zhao Y, et al
    Machine learning in early screening for high-grade cervical intraepithelial neoplasia using blood testing.
    BMC Med Inform Decis Mak. 2025;26:25.
    PubMed    
    Abstract available

  122. BARTHOLOMEW K, Yang LPH, Neville C, Maxwell A, et al
    Opportunistic offer of human papillomavirus (HPV) self-testing in ethnically diverse primary care clinics in Aotearoa New Zealand: an implementation study.
    BMC Prim Care. 2025;27:24.
    PubMed    
    Abstract available

  123. KYEI GK, Kyei EK
    Expanding HPV Vaccination in the United States Through Policy Action: A Call for Legislative Support.
    Policy Polit Nurs Pract. 2026;27:165-170.
    PubMed    
    Abstract available

  124. EFFAH K, Tekpor E, Amuah JE, Goka E, et al
    Expanding access to HPV screening through community health insurance schemes: lessons from a screening exercise for teachers in Ghana.
    BMC Health Serv Res. 2025;26:75.
    PubMed    
    Abstract available

  125. WANG S, Zhang C, Li T, Luo P, et al
    Association of Toll-like receptor signaling molecule gene polymorphisms with risk of cervical lesions in HPV-infected women.
    BMC Infect Dis. 2025;25:1672.
    PubMed    
    Abstract available

  126. SHEPPARD AJ, Sutradhar R, Liu N, Kewayosh A, et al
    Population-Level Outcomes for Screening Program Cancers in First Nations People in Ontario, Canada.
    JAMA Netw Open. 2026;9:e2622718.
    PubMed    
    Abstract available

  127. LUO B, Lin Z, Chen J, Wang Y, et al
    Real-world effectiveness of HPV vaccination against high-risk type HPV DNA positivity among adult women aged 18 - 45years in China: A matched test-negative design study.
    Hum Vaccin Immunother. 2026;22:2693440.
    PubMed    
    Abstract available

  128. TRZESZCZ M, Jach R
    p16/Ki-67 dual-stain immunocytochemistry in precision cervical cancer prevention: immunoprofile and clinical decision-making.
    Pol J Pathol. 2026;77:195-202.
    PubMed    
    Abstract available

  129. MAO F, Campos NG, Cheung LC
    Data-augmented multistate modeling for chronic disease processes using cross-sectional studies: application to HPV and cervical precancer.
    Biostatistics. 2026;27:kxag022.
    PubMed    
    Abstract available

  130. MREMA A, Tarimo Q, Lidenge SJ, Shungu R, et al
    Factors associated with depression among women living with HIV and cervical cancer in Tanzania: a cross-sectional study.
    Ecancermedicalscience. 2026;20:2128.
    PubMed    
    Abstract available

  131. SHENG Y, Chang Y, Jiang Y, Wang S, et al
    Concurrent Chemoradiotherapy Plus Immunotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer: A Randomized, Single-Center, Phase II Trial of Early Tumor Regression and Pro-Inflammatory Tumor Microenvironment Remodeling.
    MedComm (2020). 2026;7:e70856.
    PubMed    
    Abstract available

  132. RONSINI C, Di Nuzzo A, Cucinella G, Solazzo MC, et al
    Parametrial involvement in cervical cancer is associated with systemic inflammatory indices: a retrospective observational study.
    Front Med (Lausanne). 2026;13:1842260.
    PubMed    
    Abstract available

  133. AJORLOO M, Alamdary A, Samaie S, Arabi Mianroodi R, et al
    Oncolytic Effects of S89K Matrix Protein of Vesicular Stomatitis Virus in Cervical Cancer.
    Adv Biomed Res. 2026;15:28.
    PubMed    
    Abstract available

  134. LANYO GS, Nabe B, Tutu AO, Asore MA, et al
    Determinants of cervical screening in Ghana: a systematic review.
    BMJ Open. 2026;16:e111770.
    PubMed    
    Abstract available

  135. ZHANG J, Li B, He J, Shu X, et al
    A retrospective study with a 5-year follow-up on the effectiveness of transcatheter arterial chemoembolization for locally advanced cervical cancer.
    J Vasc Interv Radiol. 2026 Jul 9:108945. doi: 10.1016/j.jvir.2026.108945.
    PubMed    
    Abstract available

  136. LIN X, Xie L, Shao K, Jing J, et al
    Unveiling the identification of the genetic features and biological characteristics shared between cervical cancer and venous thromboembolism.
    Comput Biol Chem. 2026;124.
    PubMed    
    Abstract available

  137. NETHERTON TJ, Aggarwal A, Alakayleh Q, Beadle BM, et al
    Artificial Intelligence-Powered Radiotherapy for Resource-Limited Settings: Advancing Cervical and Prostate Cancer Treatment Planning With the Radiation Planning Assistant.
    JCO Glob Oncol. 2026;12:e2500702.
    PubMed    
    Abstract available

  138. ABADIA ACM, Trujillo Chacon LM, Willig JB, Osorio E, et al
    Comparative Evaluation of the Cytotoxic Effect of Dysphania ambrosioides Extracts Against Human Breast and Cervical Cancer Cells.
    Chem Biodivers. 2026;23:e71452.
    PubMed    
    Abstract available

  139. MOURA M, Bras IM, Alves C, Aguiar T, et al
    Acquired Vulvar Lymphangiomatosis: A Rare Condition After Cervical Cancer Treatment.
    Clin Case Rep. 2026;14:e73117.
    PubMed    
    Abstract available

  140. SHARMA AM, David S, Suresh P, Krishna SS, et al
    Diverse non-vaccine high-risk HPV genotypes in rural Kerala: implications for cervical cancer prevention in an underserved population.
    Infect Agent Cancer. 2026 Jul 8. doi: 10.1186/s13027-026-00778.
    PubMed    
    Abstract available

  141. GREEN BB, Mogk J, Crawford-Gallagher B, Beatty TC, et al
    Impact of a Clinic- and Mail-Based Cervical Cancer Human Papillomavirus Self-Collect Screening Program.
    NEJM Catal Innov Care Deliv. 2026;7:CAT250420.
    PubMed    
    Abstract available

  142. ZHU X, Xiang J, Bai J, Wang L, et al
    Downregulation of miR-3074-5p slows cervical cancer progression by targeting TGFBR2 expression.
    Ir J Med Sci. 2026 Jul 8. doi: 10.1007/s11845-026-04488.
    PubMed    
    Abstract available

  143. BERDICHEVSKY B A, Pavlova I V, Berdichevsky V B, Gonyaev A R, et al
    [Clinical digitalization of visual manifestations of late radiation cystitis (pilot study)].
    Urologiia. 2026;:24-29.
    PubMed    
    Abstract available

  144. ZHANG C, Zheng W, Wang X, Wang Z, et al
    Adjunctive photodynamic therapy improves outcomes and quality of life in condyloma acuminatum after radical cervical cancer surgery.
    Front Oncol. 2026;16:1848211.
    PubMed    
    Abstract available

  145. DIAZ DEL ARCO C, Aguilera Hervas M, Ramirez Mena M, Garcia Martinez R, et al
    High-Risk Human Papillomavirus Prevalence and Genotype Distribution in Two Opportunistic Cervical Screening Periods in Spain: A Tertiary Hospital-Based Study.
    APMIS. 2026;134:e70234.
    PubMed    
    Abstract available

  146. REMKES A, Gheit T, Martinez-Perez GZ, Fusco D, et al
    Moving Beyond the Female-Only Paradigm: Arguments for Accelerating the Global Gender-Neutral Human Papillomavirus Vaccination.
    Cancer Control. 2026;33:10732748261466385.
    PubMed    
    Abstract available

  147. LIU M, Zhang L, Fan Y, Han L, et al
    HPV Infection Drives CXCL8(+) Neutrophil-Mediated Immune Suppression in Cervical Cancer.
    Biofactors. 2026;52:e70131.
    PubMed    
    Abstract available

  148. ZABRIAN C, Vanoost A, Theret P, Mancaux A, et al
    [Long-term oncological outcomes and morbidity and mortality associated with radical hysterectomy by laparoscopy versus laparotomy for early-stage cervical cancer].
    Gynecol Obstet Fertil Senol. 2026 Jul 7:S2468-7189(26)00183.
    PubMed    
    Abstract available

  149. SACINTI KG, Sonmezer M
    Surgical radicality and fertility preservation in early cervical cancer: An evolving paradigm.
    Surg Oncol. 2026;67:102474.
    PubMed    


  150. SUZUKI T, Takahashi R, Tachibana H, Oda S, et al
    Patient stratification for dose scaling in cervical cancer: a model-based analysis using image-guided adaptive brachytherapy.
    J Radiat Res. 2026 Jul 7:rrag047. doi: 10.1093.
    PubMed    
    Abstract available

  151. XU K, Zhang G
    Diagnostic Value of SCC-Ag Combined With CYFRA 21-1 in Predicting Long-Term Lymph Node Metastasis After Cervical Cancer Surgery.
    Br J Hosp Med (Lond). 2026;87:55133.
    PubMed    
    Abstract available

  152. TOMMO TCHOUAKET MC, Gabisa JE, Ngoufack Jagni Semengue E, Moko Fotso LG, et al
    Interoperability of two commercial kits in detecting high oncogenic human papilloma virus and genetic diversity in Cameroon: implications for cervical cancer screening strategies in resource-limited settings.
    Infect Agent Cancer. 2026;21:51.
    PubMed    
    Abstract available

  153. AHUJA R, Sharma K, Kumar Tiwari A, Uttam V, et al
    Comparative clinical significance of HPV DNA, HPV E6/E7 mRNA, and p16(INK4a) in cervical cancer among Indian and USA populations: a meta-analysis and systematic review.
    Sci Rep. 2026 Jul 7. doi: 10.1038/s41598-026-59440.
    PubMed    
    Abstract available

  154. RAHIM F, Atasever U
    The population impact of human papillomavirus vaccination on cancer and pre-cancer outcomes: An umbrella review of meta-analyses.
    Hum Vaccin Immunother. 2026;22:2699584.
    PubMed    
    Abstract available

  155. BONALA SR, Subramanian BV, Venati C, Selvamary H, et al
    Improving compliance with curative radiotherapy for cervical cancer in a high-volume centre in India: a bundled workflow (AID-CARE) quality improvement project.
    BMJ Open Qual. 2026;15:e003874.
    PubMed    
    Abstract available

  156. SHOGAN JC, Sukumvanich P, Boisen M, Courtney-Brooks M, et al
    Ovary Sparing Intensity Modulated Radiotherapy Following Ovarian Transposition: A Single Institution Retrospective Dosimetric Analysis of Patients with Cervical Cancer Treated with External Beam Radiation Therapy After Oophoropexy.
    Pract Radiat Oncol. 2026 Jul 6:S1879-8500(26)00195.
    PubMed    
    Abstract available

  157. LI Z, Li M, Tian M, Zhou M, et al
    Efficacy Analysis of Paiteling in Treating Persistent High-Risk Human Papillomavirus after Cervical Cancer Surgery.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available

  158. JULIAN ON, Velarde I, Advani SJ, Mayadev J, et al
    Past present and future of radiosensitization in cervical cancer.
    Front Oncol. 2026;16:1846581.
    PubMed    
    Abstract available

  159. LIN X, Zheng J, Li Y, Wang S, et al
    Oncogenic DNMT3B as a therapeutic target for cervical cancer.
    Chin Med J (Engl). 2026 Jul 3. doi: 10.1097/CM9.0000000000004130.
    PubMed    
    Abstract available

  160. ANGELO C, Robinson K
    Cervical Cancer Elimination Must Centre Aboriginal and Torres Strait Islander Women.
    Health Promot J Austr. 2026;37:e70214.
    PubMed    
    Abstract available

  161. CHAVIS YC, Jin R, Leach DF 3rd, Walker KV, et al
    Addressing barriers to care: A proposed model to predict prolonged treatment time among patients with locally advanced cervical cancer.
    Brachytherapy. 2026 Jul 4:S1538-4721(26)00082.
    PubMed    
    Abstract available

  162. CUSIMANO MC, Poxon A, Gien LT, Sutradhar R, et al
    Association of Surgical Approach with Oncologic Outcomes in Low-Risk Cervical Cancer.
    Am J Obstet Gynecol. 2026 Jul 4:S0002-9378(26)00348.
    PubMed    
    Abstract available

  163. HU Y, Liu X, Zhang Z, Zhou J, et al
    Signaling pathways in tobacco smoking-induced cervical carcinogenesis: Beyond HPV-mediated activation.
    Toxicol Lett. 2026;422:113148.
    PubMed    
    Abstract available

  164. YI H, Liu Y, Yin X, Huang J, et al
    Long-Term Outcomes After Cervical Cold Knife Conization or Loop Electrosurgical Excision Procedure.
    JAMA Surg. 2026;161:737-744.
    PubMed    
    Abstract available

  165. LIU Y, Qu H, Zhang F, Gan S, et al
    Comparative performance of L1- and E6/E7-targeted HPV genotyping assays based on a unified MeltArray platform.
    Microbiol Spectr. 2026;14:e0020626.
    PubMed    
    Abstract available

  166. BEIRA SALVADOR PM, Garcia Grandal T, Iglesias Mendez R
    Risk of HSIL/CIN2+ Lesions in Women with Negative Cytology and High-Risk HPV Referred to Colposcopy: Experience in a Population-Based Screening Program.
    Med Clin (Barc). 2026;166:107451.
    PubMed    
    Abstract available

  167. BARTHOLOMEW K, Yang LPH, Neville C, Maxwell A, et al
    An implementation study of text invitation, mailed at-home human papillomavirus (HPV) self-testing and telehealth management in Aotearoa New Zealand, with a nested randomised controlled trial that compared offering an incentive vs. no offer with a rep
    BMC Public Health. 2026;26:2108.
    PubMed    
    Abstract available

  168. ESSAYAGH T, Essayagh M, Lemriss H, Mourad R, et al
    Prevalence and determinants of human papillomavirus vaccine hesitancy among parents of young girls in Morocco.
    Sci Rep. 2026;16:21387.
    PubMed    
    Abstract available

  169. STONYTE V, Fjeldbo CS, Langiu M, Joy-Immediato M, et al
    Elevated GCN2 levels in cancer cells confer protection from mitotic stress and faster cell movement.
    Cell Oncol (Dordr). 2026;49:92.
    PubMed    
    Abstract available

  170. HE M, Huang S, Wang M, Zhu T, et al
    A DLEU2/E2F1 regulatory axis promotes migration and invasion phenotypes in cervical squamous cell carcinoma.
    Sci Rep. 2026;16:20883.
    PubMed    
    Abstract available

  171. DIRICAN CD, Jumean S, Dhanesar G, Maroules M, et al
    Cancer Prevention in Women with Sickle Cell Disease: A Scoping Review of HPV Vaccination and Cancer Screening.
    J Womens Health (Larchmt). 2026;35:871-875.
    PubMed    
    Abstract available

  172. LI JJ, Yang SS, Chen KJ, Jiang LS, et al
    REBACIN((R)) can remove high-risk Human Papillomavirus (HPV) persistent infection efficiently as an effective non-invasive treatment: a multicenter prospective study.
    World J Surg Oncol. 2026;24:283.
    PubMed    
    Abstract available

  173. ZHOU H, Dai Y, Zhang H, Yang Y, et al
    P16/Ki67 dual staining versus cytology for identifying high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) in triage management of HR-HPV-positive women: a systematic review and meta-analysis.
    J Gynecol Oncol. 2026;37:e68.
    PubMed    
    Abstract available

  174. CUI M, Zhang M, Zhang J, Mao R, et al
    Cervicovaginal dysbiosis and microenvironment disruption are associated with cervical carcinogenesis.
    Microbiol Spectr. 2026;14:e0280424.
    PubMed    
    Abstract available

  175. PARK SM, Choi CH, Kim K, Kim H, et al
    Cervical neuroendocrine carcinoma with non-neuroendocrine components has a poorer prognosis than pure neuroendocrine carcinoma.
    J Gynecol Oncol. 2026;37:e80.
    PubMed    
    Abstract available

  176. QU W, Wang H, Jin N, Tang Q, et al
    Comparing paclitaxel and platinum-based concurrent chemoradiotherapy with short-term adjuvant chemotherapy versus platinum-based monotherapy concurrent chemoradiotherapy in patients with postoperative gastric-type endocervical adenocarcinoma with high
    J Gynecol Oncol. 2026;37:e79.
    PubMed    
    Abstract available

  177. KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
    Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening.
    Am J Epidemiol. 2026 Feb 27:kwag040. doi: 10.1093.
    PubMed    
    Abstract available

  178. FANTOZZI PJ, Sonis ST, Diaz JP, Villa A, et al
    Oral mucositis secondary to datopotamab deruxtecan for advanced-stage cancer managed with cryotherapy after topical steroid failure: A case series study.
    J Am Dent Assoc. 2026;157:787-794.
    PubMed    
    Abstract available

  179. LIU X, Yang Y, Zhang B, Gao X, et al
    Flubendazole inhibits cervical carcinoma by targeting DHODH to induce ferroptosis and mitophagy.
    Biochem Pharmacol. 2025;242.
    PubMed    
    Abstract available

  180. KONG WY, St Sauver JL, Jacobson RM, MacLaughlin KL, et al
    Cervical cancer screening preferences by sexual orientation among persons assigned female at birth.
    BMC Womens Health. 2026 Jul 17. doi: 10.1186/s12905-026-04678.
    PubMed    
    Abstract available

  181. LIU Z, Liu W, Liu Z
    Molecular mechanisms and adjuvant therapeutic potential of alpha-mangostin in cervical cancer.
    Discov Oncol. 2026 Jul 17. doi: 10.1007/s12672-026-05534.
    PubMed    
    Abstract available

  182. LU TF, Shih YH, Chen YF, Fan CT, et al
    Association of Hormone Therapy with Long-Term Outcomes After Chemoradiation for Locally Advanced Cervical Cancer.
    Am J Obstet Gynecol. 2026 Jul 17:S0002-9378(26)00366.
    PubMed    
    Abstract available

  183. RODRIGUEZ JA, Mejia Vargas NJ, Moreno Acuna JE
    Peritoneal angiosarcoma in a patient with a history of cervical cancer treated with radiotherapy: A case report.
    Rev Esp Patol. 2026;59:100891.
    PubMed    
    Abstract available

  184. JIA J, Wang L, Wang F
    Patient Selection and Treatment Heterogeneity in Evaluating Radiotherapy for Metastatic Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2026;57:104282.
    PubMed    


  185. JIA J, Wang L, Wang F
    Nodal Tumour Burden as a Prognostic Marker: Interpreting Volume-Based Risk Stratification in Para-Aortic Node-Positive Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2026;57:104283.
    PubMed    


  186. MCARDLE RP, Morgan J, Itsura P, Paneru B, et al
    Triangular Partnership in Oncology: The Kenya-Nepal Oncology Network Project for the Control of Breast and Cervical Cancer in Kenya and Nepal.
    JCO Glob Oncol. 2026;12:e2500762.
    PubMed    
    Abstract available

  187. TOMIZAWA K, Sakamoto S, Miyasaka Y, Oike T, et al
    MYC upregulation as candidate predictive biomarker for radioresistance in cervical cancer.
    Jpn J Radiol. 2026 Jul 17. doi: 10.1007/s11604-026-02036.
    PubMed    
    Abstract available

  188. ABOUELELLA DK, Knettel B, Mwobobia J, Posani S, et al
    Examining stigma associated with human papillomavirus (HPV) and cervical cancer screening and treatment in Africa: a scoping review.
    Glob Ment Health (Camb). 2026;13:e138.
    PubMed    
    Abstract available

  189. CHEN H, Yang X, Qin Y, Xu W, et al
    Efficacy and safety of immune checkpoint inhibitors combined with anti-angiogenic agents for advanced cervical cancer: A systematic review and meta-analysis.
    Oncol Lett. 2026;32:387.
    PubMed    
    Abstract available

  190. BEREZA K, Kukielka A, Trojnarska D, Grabarek BO, et al
    Multidimensional assessment of urinary dysfunction and quality of life after cervical cancer treatment: a multicenter study integrating urodynamics and patient-reported outcomes.
    Front Oncol. 2026;16:1853725.
    PubMed    
    Abstract available

  191. IDEN M, Schmidt R, Mohammed RDAS, Dlugi TA, et al
    TAOK3 inhibition constrains invasion, potentiates paclitaxel, and reprograms the tumor microenvironment toward anti-tumor immunity in cervical cancer.
    bioRxiv [Preprint]. 2026 Jul 6:2026.07.04.736128.
    PubMed    
    Abstract available

  192. ZHU B, Ge Y, Wen Y, Wu Y, et al
    DDOST mediates cervical cancer cell malignant progression by interacting with SMARCA4.
    Am J Cancer Res. 2026;16:2377-2388.
    PubMed    
    Abstract available

  193. GUO Y, Zhang Y, Zhang S, Guo J, et al
    UBE2J2-mediated ubiquitination modification of MCM6 regulates proliferation and migration of cervical cancer cells.
    Am J Cancer Res. 2026;16:2355-2366.
    PubMed    
    Abstract available

  194. XU Y, Li S, Wang B, Huang J, et al
    Impact of laparoscopic versus open surgery on 5-year survival in patients with stage IA2-IB1 cervical cancer: a retrospective cohort study.
    Am J Cancer Res. 2026;16:2577-2611.
    PubMed    
    Abstract available

  195. ZHAO Y, Zhou H
    Serum USP1 and PD-L1 levels independently predict treatment response and prognosis in cervical cancer: a retrospective cohort study.
    Am J Cancer Res. 2026;16:2458-2480.
    PubMed    
    Abstract available

  196. SU L, Chen R, He T, Su X, et al
    USP5 promotes glycolysis in cervical cancer by stabilizing FOXM1.
    Am J Cancer Res. 2026;16:2329-2341.
    PubMed    
    Abstract available

  197. WANG J, Lin F, Chen X
    Efficacy of immune checkpoint inhibitors plus chemotherapy versus chemotherapy-based control in cervical cancer: a meta-analysis.
    Am J Cancer Res. 2026;16:2131-2147.
    PubMed    
    Abstract available

  198. TIAN Y, Zhang Y, Wang L, Li Z, et al
    Recent progress and therapeutic strategies in the treatment of cervical neuroendocrine neoplasms (Review).
    Int J Mol Med. 2026;58:259.
    PubMed    
    Abstract available

  199. GOKHAN ACIKGOZ S, Bakir A, Demir Cendek B, Beyaz H, et al
    Pre-treatment MRI-derived fractal dimension as a prognostic marker in cervical cancer treated with definitive radiotherapy with or without concurrent chemotherapy.
    BMC Med Imaging. 2026 Jul 16. doi: 10.1186/s12880-026-02589.
    PubMed    
    Abstract available

  200. RUBAGUMYA F, Kwizera V, Mutetiwabo I, Habimana S, et al
    Feasibility of Decentralized Cervical Cancer Survivorship Care at District Hospitals in Rwanda: A Multi-Site Pilot Implementation Study.
    Oncologist. 2026 Jul 16:oyag275. doi: 10.1093.
    PubMed    
    Abstract available

  201. KAMBLE S, Gurunani G, Bodhankar M
    Comment on "Nano-enabled targeted transdermal therapy for pain management in cervical cancer".
    J Pharm Sci. 2026 Jul 16:104421. doi: 10.1016/j.xphs.2026.104421.
    PubMed    


  202. ODEI-MENSAH B, Adeyemi SA, Choonara YE
    Response to the Letter Regarding "Nano-enabled Targeted Transdermal Therapy for Pain Management in Cervical Cancer".
    J Pharm Sci. 2026 Jul 16:104422. doi: 10.1016/j.xphs.2026.104422.
    PubMed    


  203. RAMOS AM, Bolignani CV, Gottems LBD, Costa AM, et al
    Knowledge and Awareness of HPV, the HPV Vaccine, and Cervical Cancer Among Women From a Brazilian Community: A Community-Based Cross-Sectional Study.
    Health Sci Rep. 2026;9:e72818.
    PubMed    
    Abstract available

  204. JAMMALAMADUGU SB, Tirelo L, Youssouf N, Umutesi G, et al
    Individual-level HPV vaccination verification in Botswana: lessons learned from implementation of the HOPE II trial.
    Front Public Health. 2026;14:1821335.
    PubMed    
    Abstract available

  205. OZDAS T, Donmez E, Ortabag T
    Women's experiences and perspectives on a nurse navigation program for cervical cancer screening: a qualitative study.
    Front Public Health. 2026;14:1883702.
    PubMed    


  206. WANG Y, Gui X
    Bavachinin induces oxidative stress-associated apoptosis and modulates NF-kappaB-associated inflammatory gene expression in cervical cancer cells.
    Cytotechnology. 2026;78:159.
    PubMed    
    Abstract available


  207. LOXL 2 Promotes the Epithelial-Mesenchymal Transition and Malignant Progression of Cervical Cancer [Retraction].
    Onco Targets Ther. 2026;19:636792.
    PubMed    
    Abstract available

  208. GROS C, Goulenok T, Timsit JF, Sacre K, et al
    Risk of cancer induced by human papillomavirus in patients with immune-mediated inflammatory diseases: a nationwide matched cohort study.
    RMD Open. 2026;12:e006927.
    PubMed    
    Abstract available

  209. GOULENOK T, Sierra C, Florence AM, Gonthier C, et al
    Prevalence and risk factors for high-risk human papillomavirus infection in patients with immune-mediated inflammatory diseases: a prospective study.
    RMD Open. 2026;12:e006955.
    PubMed    
    Abstract available

  210. LIU C, Dong C, Qu L, Jiang X, et al
    Abrine inhibits cervical cancer progression by targeting UGT8.
    Tissue Cell. 2026;104.
    PubMed    
    Abstract available

  211. MISHRA SK, Yeager M, Nelson CW, Zhu B, et al
    Longitudinal analysis of high-risk HPV infections reveals within-host viral genome changes over time.
    PLoS Pathog. 2026;22:e1014362.
    PubMed    
    Abstract available

  212. MENON SS, Gupta M, Bhardwaj A, G Chandraguthi S, et al
    A prospective development and evaluation of a 2D convolutional neural network-based auto-segmentation model for cervical cancer radiotherapy.
    J Egypt Natl Canc Inst. 2026;38:46.
    PubMed    
    Abstract available

  213. SERT F, Serin G, Alanyali S, Ozturk M, et al
    HIF-1alpha falls short, ERCC-1 stands out: Predictive insights in locally advanced cervical cancer.
    Histol Histopathol. 2026 Jul 15:25125. doi: 10.14670.
    PubMed    
    Abstract available

  214. NITTAYABOON K, Leetanaporn K, Kerdkumthong K, Mayakun J, et al
    Cytotoxic Effect of Halimeda macroloba Crude Extract on Cervical Cancer Spheroid Cells via p-mTOR/mTOR, Apoptosis, and Ferroptosis Pathways.
    Cancer Manag Res. 2026;18:611650.
    PubMed    
    Abstract available

  215. OOMMEN AM, Thomas V, Muliyil DE, John NO, et al
    Disparities in survival after cervical cancer between tribal and rural women in Tamil Nadu, India: A retrospective cohort study.
    J Family Med Prim Care. 2026;15:1762-1768.
    PubMed    
    Abstract available

  216. JEDRZEJCZYK A, Mawlichanow K, Golec-Cera A, Oplawski M, et al
    Robotic Versus Open Radical Hysterectomy in Early-Stage Cervical Cancer: A Comparative Cohort Study.
    J Clin Med. 2026;15:5168.
    PubMed    
    Abstract available

  217. AGUSTINA HR, Haroen H, Pahria T, Winarno GNA, et al
    Family Voices in Digital Patient Navigation for Cervical Cancer Care in Indonesia.
    Healthcare (Basel). 2026;14:1809.
    PubMed    
    Abstract available

  218. SIFUENTES-PADILLA JL, Granados-Lopez AJ, Campos-Lujan AM, Suarez-Castro A, et al
    Naphthoquinone-Amino Acids Regulate Cellular Cancer Associated Processes, p53 and miR-34a-5p Expression in Immortal and Tumorigenic Cervical Cell Lines.
    Int J Mol Sci. 2026;27:5703.
    PubMed    
    Abstract available

  219. ALBZOUR N, Lam SS
    Systematic Evaluation of Vision Transformers for Automated Cervical Cancer Classification: Optimization, Statistical Validation, and Clinical Interpretability.
    Cancers (Basel). 2026;18:2178.
    PubMed    
    Abstract available

  220. OBANDO-RODRIGUEZ JS, Vieira-Serna S, Peralta J, Rodriguez J, et al
    Para-Aortic Lymph Node Staging and Oncologic Outcomes in Locally Advanced Cervical Cancer: A Narrative Review.
    Cancers (Basel). 2026;18:2058.
    PubMed    
    Abstract available

  221. PEI K, Li D, Xi M, Zhang J, et al
    Nomogram for Preoperative Prediction of Adjuvant Therapy Requirement Following Radical Surgery in Stage IB Cervical Squamous Cell Carcinoma With Tumor Size
    Cancer Med. 2026;15:e72114.
    PubMed    
    Abstract available

  222. CHENG J, Li M, Li C, Ding J, et al
    Global Trends and Insights in Cervical Cancer Research: A Bibliometric Analysis from 2000 to 2024.
    Reprod Fertil. 2026 Jul 14:RAF-25-0174. doi: 10.1530/RAF-25-0174.
    PubMed    
    Abstract available

  223. FAROLFI A, Casadei C, Scarpi E, Paoletti E, et al
    Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer.
    JAMA Netw Open. 2026;9:e2623166.
    PubMed    
    Abstract available

  224. YANG H, Li X, Cai Z, Li Y, et al
    Synthesis and growth inhibitory activity of sinomenine derivatives against cervical cancer SiHa cells through targeting the AKT-CyclinD1-p21/p27 pathway.
    Med Chem Res. 2026 Jun 8. doi: 10.1007/s00044-026-03584.
    PubMed    
    Abstract available

  225. WAHID A, Maharaj R, Meiring M, Anand K, et al
    Extracellular Vesicles as Emerging Cervical Cancer Diagnostic and Molecular Signatures of Tumor and Immune Dynamics.
    ACS Biomater Sci Eng. 2026 Jul 14. doi: 10.1021/acsbiomaterials.6c00063.
    PubMed    
    Abstract available

  226. THAKUR P, Singh K, Lakhanpal V, Gupta M, et al
    Comparative analysis of LDR and HDR intracavitary brachytherapy in cervical cancer: the critical role of overall treatment time - a decade of experience.
    Rep Pract Oncol Radiother. 2026;31:330-340.
    PubMed    
    Abstract available

  227. NDUKWE MI, Balcarova K, Spacek J, Pohankova D, et al
    Fistula occurrence after definitive chemoradiotherapy in metastatic or persistent cervical cancer: a retrospective cohort study.
    Rep Pract Oncol Radiother. 2026;31:322-329.
    PubMed    
    Abstract available

  228. DOZIE UW, Favour Chisom N, Nwokorie MA, Dozie KCN, et al
    Factors Affecting Pap Smear Screening Among Women of Reproductive Age in Owerri West LGA, Imo State, South-Eastern Nigeria.
    J Prev Med Hyg. 2026;67:E87-E95.
    PubMed    
    Abstract available

  229. ABID A, Noor M, Maheshwari P, Saeed MH, et al
    Addressing HPV Vaccine Hesitancy: A Crucial Step Toward Cervical Cancer Prevention in Pakistan.
    J Prev Med Hyg. 2026;67:E7-E8.
    PubMed    


  230. CHEN G, Jiang Q, Xu J, He T, et al
    A senescence-based machine learning model prognosticates and personalizes therapy in cervical cancer.
    Transl Cancer Res. 2026;15:490.
    PubMed    
    Abstract available

  231. HUANG S, Song Y, Zhao Y, Zhang X, et al
    Ailanthone as a novel AKT1 inhibitor that induces mitochondrial apoptosis and exerts anti-tumor activity in cervical cancer.
    Transl Cancer Res. 2026;15:465.
    PubMed    
    Abstract available

  232. WANG M, Xiong S, Qiu X, Hu Z, et al
    Development and Validation of a Prognostic Model for Cervical Cancer Based on Chlamydia trachomatis-Associated Transcriptional Signatures.
    Int J Womens Health. 2026;18:611743.
    PubMed    
    Abstract available

  233. YANG F, Zhu M, Qiu J, Chen Y, et al
    PCK2 Promotes Ribosome Biogenesis in Cervical Cancer Cells via Interaction with hnRNPK.
    Reprod Sci. 2026 Jul 13. doi: 10.1007/s43032-026-02143.
    PubMed    
    Abstract available

  234. NAYAK P, Chopra S, Gupta Y, Saahil W, et al
    Response to letter to editor "Radiomics-based machine-learning approach to predict response at brachytherapy using pretreatment magnetic resonance imaging in locally advanced cervical cancer".
    Brachytherapy. 2026 Jul 13:S1538-4721(26)00069.
    PubMed    


  235. RAKHAT A, Aimagambetova G
    Cervical Cancer Screening in Transition: Global Challenges and Local Realities.
    Int J Womens Health. 2026;18:607741.
    PubMed    
    Abstract available

  236. ZHOU Y, Zheng X, Shao D, Cheng F, et al
    Facilitators and barriers to cervical cancer screening among women living with HIV: a systematic review of qualitative studies.
    Front Public Health. 2026;14:1809112.
    PubMed    
    Abstract available

  237. GUO Y, Liu Y, He Y, Zhang Y, et al
    HPV viral load predicts immune exhaustion and prognosis in cervical neoplasia.
    Front Immunol. 2026;17:1840435.
    PubMed    
    Abstract available

  238. WEI Q, Qu H, Yu Y, Gao S, et al
    Neoadjuvant chemotherapy and immunotherapy followed by radical radiotherapy for locally advanced cervical cancer: efficacy and safety.
    Front Immunol. 2026;17:1784958.
    PubMed    
    Abstract available

  239. CULCASI C, Moro F, Merenda E, Rizzi A, et al
    Occult sentinel lymph node metastasis detected by intraoperative ex vivo high-frequency ultrasound in clinically early-stage cervical cancer: a case from the prospective RHINOCERUS study.
    Gynecol Oncol Rep. 2026;66:102162.
    PubMed    
    Abstract available

  240. YOON JW, Kim G, Lee ES, Lee SY, et al
    Cervical cancer screening and HPV vaccination among assigned female at birth transgender and gender-diverse individuals in South Korea: findings from the KITE cohort.
    BMC Public Health. 2026 Jul 13. doi: 10.1186/s12889-026-28224.
    PubMed    
    Abstract available

  241. HOEGL J, Fernandes A, Hidalgo F, Escalona S, et al
    Diagnostic value of routine endoscopic studies in staging locally advanced cervical cancer: a multicenter experience from a low and middle-income country.
    Ecancermedicalscience. 2026;20:2139.
    PubMed    
    Abstract available

  242. KIAEE M, Entezari M, Jebali A, Hashemi M, et al
    Bimetallic nano mixtures enable rapid ultrasensitive detection of high risk HPV for early cervical cancer diagnosis.
    Discov Nano. 2026;21:337.
    PubMed    
    Abstract available

  243. JIANG P, Wang X, Cui S, Ren C, et al
    Solution for the hot spots in adaptive radiotherapy planning for cervical cancer: a case report and review of literature.
    Front Oncol. 2026;16:1862463.
    PubMed    
    Abstract available

  244. JIANG J, Gao Y, Wang M, Zhang R, et al
    Metabolomic data of melittin-intervened murine cervical cancer cells based on liquid chromatography-mass spectrometry.
    Data Brief. 2026;67:113051.
    PubMed    
    Abstract available

  245. HASSAN AA, Sudi LA, Mohamed MD, Abdullahi YB, et al
    Persistently high cervical cancer mortality in India: Beyond screening modality alone.
    Glob Epidemiol. 2026;12:100273.
    PubMed    


  246. WHITE CB, McGregor LM
    '...but look how many lives would have been saved if this was available then' Exploring the acceptability of future Human Papillomavirus self-sampling, and the barriers and facilitators of cervical cancer screening for those with intellectual disabili
    Br J Health Psychol. 2026;31:e70092.
    PubMed    
    Abstract available

  247. POURETTE D, Cripps A, Hassine A, Opigez E, et al
    Motivation, Capacity and Opportunities for Cervical Cancer Home-based Vaginal Self-sampling in Reunion Island: a Qualitative Study.
    BMC Public Health. 2026 Jul 11. doi: 10.1186/s12889-026-28369.
    PubMed    
    Abstract available

  248. MOHAMMADIAN S, Seifi Alan M, Rastad H
    CO(2) laser ablation versus conization for cervical intraepithelial neoplasia grade 2: a prospective cohort study.
    Lasers Med Sci. 2026;41:148.
    PubMed    
    Abstract available

  249. MUKHERJEE A, Chakraborty D, Khamle AR, Sharma DD, et al
    Deciphering the Anticancer Potential of Bifidobacterium longum MB BBLM15 Derived Postbiotic Metabolites in Cervical Cancer: In Vitro, In Silico, and Synergy Studies.
    Probiotics Antimicrob Proteins. 2026 Jul 11. doi: 10.1007/s12602-026-11120.
    PubMed    
    Abstract available

  250. CHEN ML, Chu CY, Zhang FX, Zhang LP, et al
    MiR-4327 targets TP53 to promote cervical cancer cell proliferation.
    Funct Integr Genomics. 2026;26:187.
    PubMed    
    Abstract available

  251. PAN S, Wu Q, Liu H, Zhou Y, et al
    ATP7A-mediated copper ion efflux reprogrammes tumour immunity and promotes cisplatin resistance in cervical cancer.
    Cell Death Dis. 2026 Jul 10. doi: 10.1038/s41419-026-09082.
    PubMed    
    Abstract available

  252. GANGA VS, Esakkimuthu S, Subramaniam S
    Integrative network pharmacology and genomic analysis of esculin targeting PARP1 in cervical cancer: Insights from ADME profiling, molecular docking, and biomarker discovery.
    Comput Biol Chem. 2026;124.
    PubMed    
    Abstract available

  253. YBASETA-MEDINA J, Munive-Bendezu R, Flores-Hernandez N, Curotto-Palomino L, et al
    Association between cervical ectropion and high-grade cervical dysplasia in women of reproductive age.
    BMC Womens Health. 2026;26:352.
    PubMed    
    Abstract available

  254. WANG Y, Yao Y, Shi H, Lu W, et al
    Analysis of SOX2 and SOX17 expression in cervical HPV-associated adenocarcinoma in situ: Correlation with histologic variants.
    Ann Diagn Pathol. 2026;84:152674.
    PubMed    
    Abstract available

  255. ARSLAN S, Barbaud A, Bernauer J, Avoscan L, et al
    Small extracellular vesicle-mediated transfer of HPV16 transcripts from Ca Ski cells increases proliferation of HPV-negative recipient cancer cells.
    Cell Commun Signal. 2026;24:404.
    PubMed    
    Abstract available

  256. NAICKER N, Liebenberg L, Naidoo K, Osman F, et al
    Diagnostic accuracy of the Xpert HPV assay in women starting antiretroviral treatment in South Africa.
    Int J STD AIDS. 2026 Jun 14:9564624261459075. doi: 10.1177/09564624261459075.
    PubMed    
    Abstract available

  257. HOSSEIN ZADEH S, Habibnia S, Rokni M
    Prevalence and genotype distribution of human papillomavirus (HPV) in an at-risk and suspected population in Iran.
    BMC Infect Dis. 2026;26:1304.
    PubMed    
    Abstract available

  258. ABUDUREHEMU S, Wang X, Wang J, Liu T, et al
    Cold-knife conization versus loop electrosurgical excision for cervical adenocarcinoma in situ: a retrospective cohort study.
    BMC Womens Health. 2026;26:348.
    PubMed    
    Abstract available

  259. HU Z, Ma L, Huang S, Wei Y, et al
    Cervi-LLM for real time colposcopy lesion detection and interpretable diagnosis.
    Sci Rep. 2026;16:22207.
    PubMed    
    Abstract available

  260. YAGI A, Ikeda S, Sakakibara A, Ito Y, et al
    Trends in age-standardized incidence rates of cancers of HPV-related cancer sites in Osaka, Japan: 1977-2019.
    Sci Rep. 2026;16:21754.
    PubMed    
    Abstract available

  261. HULMI J, Virtanen A, Sadeluoto H, Tarkkanen J, et al
    Histological outcomes and colposcopic findings in patients with persistent high-risk human papillomavirus infection without major cytological findings.
    Am J Obstet Gynecol. 2026;235:356-364.
    PubMed    
    Abstract available

  262. GAYATHRI AP, Patel A, Shah L, Chaiprasit T, et al
    Neuroendocrine Malignancies of the Cervix: What Radiologists Need to Know.
    J Comput Assist Tomogr. 2026;50:566-576.
    PubMed    
    Abstract available

  263. PUNTONEN E, Bazzon S, Bongiovanni M, Granados R, et al
    ThinPrep(R) Whole-Slide Digital Images versus Conventional Microscopy in Negative for Intraepithelial Lesion or Malignancy, Atypical Squamous Cells of Undetermined Significance, and Low-Grade Squamous Intraepithelial Lesion Cervical Lesions: European
    Pathobiology. 2026;93:221-231.
    PubMed    
    Abstract available

  264. ASSIRLIKIAN S, Mancini J, Philip CA, Canlorbe G, et al
    Predictive factors for the absence of high-grade intraepithelial lesions in LLETZ specimens following a prior histological diagnosis.
    Acta Obstet Gynecol Scand. 2026;105:1240-1246.
    PubMed    
    Abstract available

  265. BERTELSEN VM, Booth BB, Tranberg M, Petersen LK, et al
    Assessing the clinical value of cervical biopsies in individuals with transformation zone type 3 at colposcopy: A cross-sectional study.
    Acta Obstet Gynecol Scand. 2026;105:1597-1606.
    PubMed    
    Abstract available

  266. ARENA L, Alizai Q, Elemosho A, Chatzipanagiotou OP, et al
    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.
    Cancer. 2026;132:e70462.
    PubMed    
    Abstract available

  267. NOGUERAS GONZALEZ GM, Amboree TL, Parker S, Bulsara S, et al
    Barriers to cervical cancer screening and experiences using mailed at-home HPV self-collection kits among US and foreign-born Hispanic women in a safety net health system.
    Gynecol Oncol. 2026;211:238-245.
    PubMed    
    Abstract available

  268. DIXIT R, Chakrawal A, Purwar R, Pandey M, et al
    Comparative performance of HPV self-sampling and conventional screening methods: A systematic review and bivariate meta-analysis.
    Gynecol Oncol. 2026;210:84-94.
    PubMed    
    Abstract available

  269. ALAM MS, Smith LW, Gondara L, Cook D, et al
    HPV Testing Versus Cytology for Cervical Cancer Screening Among Women 50 Years and Older: Evidence From the HPV FOCAL Randomized Controlled Trial.
    Int J Cancer. 2026 Jun 27. doi: 10.1002/ijc.70616.
    PubMed    
    Abstract available

  270. HASSAN UM, Hayatu A, Farouk HU, Mohammed A, et al
    Readiness and affordability of utilizing human papillomavirus testing for cervical cancer screening among sexually active women in Gombe, Nigeria.
    Int J Gynaecol Obstet. 2026 Jul 2. doi: 10.1002/ijgo.71155.
    PubMed    
    Abstract available

  271. ZHOU H, Zhang H, Pi R, Yang Y, et al
    Head-to-head comparison of the MyGene human papillomavirus-sexually transmitted infection assay versus the Cobas 4800 human papillomavirus test for detecting high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2026;174:824-835.
    PubMed    
    Abstract available

  272. HONG Q, Smith LW, Proctor L, Gondara L, et al
    Loop electrosurgical excision procedure and perinatal outcomes post-human papillomavirus cervical screening: A longitudinal cohort study.
    Int J Gynaecol Obstet. 2026;174:793-799.
    PubMed    
    Abstract available

  273. WOLSWINKEL JT, van Lenthe I, Maurits JSF, Aarts JWM, et al
    Balancing fertility potential and oncologic and obstetric risks: a vignette study on decision-making in fertility-sparing surgery for early-stage cervical cancer.
    Int J Gynecol Cancer. 2026;36:104802.
    PubMed    
    Abstract available

  274. LEJEUNE CL, Janovska N, Wakatsuki A, Novak Z, et al
    Analysis of indocyanine green-guided sentinel lymph node mapping for cervical cancer during pregnancy.
    Int J Gynecol Cancer. 2026;36:104810.
    PubMed    
    Abstract available

  275. NORDQVIST KLEPPE S, Almstedt P, Dillner J, Arroyo Muhr LS, et al
    Design principles and core components of cervical screening registries in the human papillomavirus era: a narrative review and global framework.
    Int J Gynecol Cancer. 2026;36:104751.
    PubMed    
    Abstract available

  276. DE MELLO GRAZIANO L, Leis LV, Madia RZ, Hilgert MR, et al
    Rethinking adjuvant treatment intensification in early-stage cervical cancer after radical surgery.
    Int J Gynecol Cancer. 2026 Jun 20:104825. doi: 10.1016/j.ijgc.2026.104825.
    PubMed    


  277. RAMALHO NM, Lima Sales JTO, Carneiro VCG, Batista TP, et al
    Effect of topical vaginal estrogen after radiotherapy for cervical cancer: a randomized, double-blind pilot trial.
    Int J Gynecol Cancer. 2026;36:104831.
    PubMed    
    Abstract available

  278. QU A, Zhuo Y, Zhu H, Sun X, et al
    Nimotuzumab Plus Image-Guided Radiation Therapy for Elderly Patients with Locally Advanced Cervical Squamous Cell Carcinoma: Interim Analysis of a Prospective Multicenter Phase II Trial.
    Int J Radiat Oncol Biol Phys. 2026;125:1381-1387.
    PubMed    
    Abstract available

  279. ZHANG Y, Zou H, Deng S, Zou L, et al
    Impact of WFDC2 on the biological functions of cervical cancer cells and the regulation of the ERK/NF?kappaB signaling pathway.
    Oncol Rep. 2026;56:153.
    PubMed    
    Abstract available

  280. LIU Q, Liu W, Huang Y, Li Y, et al
    Comparative effectiveness of radical surgery versus concurrent chemoradiotherapy in stages IB3, IIA2, or locally resectable IIICr cervical cancer: a prospective, multicenter, propensity score-matched cohort study.
    BMC Cancer. 2026 Jul 1. doi: 10.1186/s12885-026-16449.
    PubMed    
    Abstract available

  281. ESMAILZADEH A, Rashki Kemmak A, Rasoulian A, Alizadeh Tabatabaei FS, et al
    Artificial intelligence for cervical cancer screening and diagnosis using Pap smear images: a systematic review.
    BMC Cancer. 2026 Jun 30. doi: 10.1186/s12885-026-16427.
    PubMed    
    Abstract available

  282. TROJNARSKA D, Trzeszcz M, Stukan M, Mazurec K, et al
    HPV vaccination beyond primary prevention: survey of practices and attitudes of Polish obstetrician-gynecologists.
    BMC Cancer. 2026 Apr 22. doi: 10.1186/s12885-026-15974.
    PubMed    


  283. WANG X, Liu Y, Li Y, An Q, et al
    The influence of postoperative risk factors on patient survival and lymph node metastasis in cervical squamous cell carcinoma.
    BMC Cancer. 2026;26:547.
    PubMed    
    Abstract available

  284. ZHU G, Chen C, Xiang Y, Wang Y, et al
    Machine learning-based prediction of long-term prognosis in cervical adenocarcinoma: a retrospective cohort study.
    BMC Cancer. 2026;26:366.
    PubMed    
    Abstract available

  285. LAMY C, Laurent L, Choussy O, Pouget N, et al
    SCANDARE: an institutional dynamic prospective interventional biobanking study.
    BMC Cancer. 2026;26:330.
    PubMed    
    Abstract available

  286. LI X, Zhang X, Dai Y, Huang F, et al
    A P4HA2 hypoxia signature derived from single cell atlas stratifies conserved subtypes with prognostic significance in cervical squamous cell carcinoma.
    BMC Cancer. 2026;26:257.
    PubMed    
    Abstract available

  287. NOGUERAS-GONZALEZ GM, Inam ME, Msadabwe S, Lee KL, et al
    Impact of social determinants of health on cervical cancer stage at presentation among women in Zambia: a cross-sectional single-center epidemiological study.
    BMC Cancer. 2026 Jul 9. doi: 10.1186/s12885-026-16315.
    PubMed    
    Abstract available

  288. MENG H, Tan L, Chen Y, Wang D, et al
    Phosphoinositide metabolism-related prognostic genes and their prognostic value in cervical cancer: an investigation based on transcriptome, single-cell analyses and verification.
    BMC Cancer. 2026 Jul 9. doi: 10.1186/s12885-026-16509.
    PubMed    
    Abstract available

  289. LEMRABETT S, Elhailouch FZ, Gourinda A, Mezzoug N, et al
    Awareness and acceptability of HPV vaccination among parents of young girls in northern Morocco: a mixed-methods study.
    BMC Cancer. 2026 May 23. doi: 10.1186/s12885-026-16111.
    PubMed    
    Abstract available

  290. KIM HJ, Lee HJ, Shin HY, Lee HS, et al
    Understanding barriers and facilitators to cervical cancer prevention among young Korean Women: A focus group interview study.
    PLoS One. 2026;21:e0353242.
    PubMed    
    Abstract available

  291. BERZA N, Zodzika J, Kivite-Urtane A, Curkste A, et al
    Factors associated with women's choice for mode of cervical sampling in future cervical cancer screening.
    PLoS One. 2026;21:e0353180.
    PubMed    
    Abstract available

  292. YANG S, Hou Y, Wang X, Kang S, et al
    Correction: Economic evaluation of atezolizumab in combination with bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer in China: A cost-effectiveness analysis.
    PLoS One. 2026;21:e0353864.
    PubMed    
    Abstract available

  293. ZOUZOULAS D, Sofianou I, Chatzistamatiou K, Theodoulidis V, et al
    Comparison of Moducare versus Wait-and-See approach for histologically proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) (MODUCIN1 TRIAL) - Study protocol.
    PLoS One. 2026;21:e0353119.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum


;